Answer
Cholesterol-lowering drugs are a direct application of Brown's research on cholesterol metabolism, contributing to improved cardiovascular health. These medications help reduce the levels of "bad" cholesterol (LDL) in the bloodstream, thereby preventing its accumulation and minimizing the risk of heart diseases such as atherosclerosis.